Posters


A comparative study between an Automated EIA analyzer and a Biochip reader for the detection of Drugs of Abuse

Castro, A., Henriques, R., Tarelho, S., Rangel, R.

Application of a Biochip Microarray ELISA-based Assay for Drugs of Abuse Screening to Meconium

Marin S.J., Merrell M., McMillin G.A.

Determination of delta 9-Tetrahydrocannabinol & 11-Nor-delta 9-Tetrahydrocannabinol-9-Carboxylic acid in Oral Fluid Using Biochip Array Analyzer and Gas Chromatography-Mass Spectrometry 

Moon-Hee Jang, Seung-Kyung Baeck, Hye-Young Choi, Hwa-Kyung Choi and Hee-Sun Chung 

Evaluation of the Evidence analyser for drugs of abuse assays

Johnson C., Vallance D., Burgess D., Labib M.

Evaluation of the Randox Whole Blood Drugs of Abuse Arrays for the Analysis of Alternative Post-mortem Toxicology Sample

McLaughlin, P.A., Pounder, D.J and Osselton, M.D.

Implementation of the Randox Evidence in Forensic Casework

Beauchamp, S., Beeson J., and Glinn, M.

Rapid Analysis of Liver, Muscle and Vitreous Humor Samples using the Randox Whole Blood Drugs of Abuse (DOA) Arrays for use as a Near-Body Screen During Autopsy

McLaughlin P.A., Pounder D.J., Cox S., Osselton D. 

The Comparison of Orasure ELISA  Reagents with Randox Biochip Reagents in Screening Barbiturates, Opiates Benzodiazepines, and Cocaine

Rein. J., Zaney, M.E., Hime, G., Hearn, W.L. 

Application of an Evidence biochip array to the simultaneous determination of Tricyclic Antidepressants, Buprenorphine, MDMA and other Drugs of Abuse (DoA I+, Whole Blood)

Darragh, J., Finnegan, C., Kelly F.M., Holmes, P., McConnell, R.I., Fitzgerald S.P.

Application of matrix dedicated evidence biochip array kits to the simultaneous determination of TCAs, Buprenorphine, MDMA and other drugs of abuse. (DoA I + Whole Blood and Urine)

Darragh, J., Finnegan, C., Kelly, F.M., Holmes, P., Piper, M., McConnell, R.I., Fitzgerald, S.P.

Biochip array-based immunoassays for the determination of Zaleplon, Zolpidem, Zopiclone in biological samples

Lowry, P., Benchikh, E. O., Jennings, A-M., McConnell, R.I., Fitzgerald, S.

Determination of Amphetamine in whole blood using Evidence Biochip Array Technology -  analytical parameters comparison with other immunoassay technique

Kinkead, R., Darragh, J., McConnell, R.I., Fitzgerald S.P.

Determination of Opiate in whole blood using Evidence Biochip Array Technology -analytical parameters comparison with other immunoassay technique

Kinkead, R., Darragh, J., McConnell R.I., Fitzgerald, S.P.

Determination of Tetrahydrocannabinol in whole blood using Evidence Biochip Array Technology: analytical parameters comparison with other immunoassay technique

Kinkead, R., Darragh, J., McConnell, R.I., Fitzgerald S.P.

Development of a high sensitivity biochip array for the simultaneous screening of  Tricyclic Antidepressants, Buprenorphine and Drugs of Abuse

Holmes P., Finnegan C., McConnell R.I., Fitzgerald S.P.

Immunoassays for the determination of Drugs of Abuse in whole blood on a biochip platform: comparison of analytical parameters with other immunoassay technique (DoA I+)

Kinkead, R., Darragh, J., Richardson, C., McConnell, R.I., Fitzgerald, S.P

Simultaneous detection of narcotics and stimulants in urine with an Evidence Biochip array kit (DoA I, Urine)

Young, M., McAleer, D., McConnell R.I., Fitzgerald S.P.

Simultaneous immunoassays on Biochip platform for multiplex screening of Benzodiazepines, Methadone, Opiates and Phencyclidine (DoA I)

Nolan, K-M., McAleer D., McConnell R.I., Fitzgerald S.

Simultaneous screening of Cannabinoids and Opiates in blood (DoA I+ Whole Blood)

Young, M., Darragh, J., Finnegan, C., Kelly, F.M., Holmes, P., McConnell, R.I., Fitzgerald S.P.